Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. - Wikidata - awgldk - TriplyDB

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

http://www.wikidata.org/entity/Q34488620

about

G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood Pressure The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production Gastrorenal Axis.Human GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition.Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade.A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter Diagnostic tools for hypertension and salt sensitivity testing.Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling Hypertension-Related Gene Polymorphisms of G-Protein-Coupled Receptor Kinase 4 Are Associated with NT-proBNP Concentration in Normotensive Healthy Adults Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.Genetic associations in preterm birth: a primer of marker selection, study design, and data analysis.Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.Alternative contingency table measures improve the power and detection of multifactor dimensionality reduction The effect of alternative permutation testing strategies on the performance of multifactor dimensionality reduction.Genetics of salt-sensitive hypertension.Variants in genes involved in functional pathways associated with hypertension in African Americans Genetic architecture of complex traits predisposing to nephropathy: hypertension.Strategies to improve detection of hypertension genes MDR-ER: balancing functions for adjusting the ratio in risk classes and classification errors for imbalanced cases and controls using multifactor-dimensionality reduction Gender-based differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years.The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.G protein-coupled receptor kinases: more than just kinases and not only for GPCRs An efficiency analysis of high-order combinations of gene-gene interactions using multifactor-dimensionality reduction.Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats.Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4 Pooled analyses of the associations of polymorphisms in the GRK4 and EMILIN1 genes with hypertension risk Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.A review of nutritional factors in hypertension management.Genomics and Pharmacogenomics of Salt-sensitive Hypertension The Role of Aldosterone in Obesity-Related Hypertension.G protein-coupled receptor kinase 4: role in blood pressure regulation Dopamine, the kidney, and hypertension.Does a medical history of hypertension influence disclosing genetic testing results of the risk for salt-sensitive hypertension, in primary care?Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.Vitamin D status, hypertension and body mass index in an urban black community in Mangaung, South Africa.Adrenergic signaling polymorphisms and their impact on cardiovascular disease.

P2860

Q26743885-20673649-0EE2-44B1-B3E4-E3AEF27D0129 Q28285535-51319F85-E0EE-49F9-A8AC-57E290E91926 Q30277035-00A96555-04B8-4D11-937B-6F5EE6074368 Q30277906-A32B288F-7243-4951-A944-3FBCE98F14F3 Q30300484-A20641C1-C584-44D4-ABFF-A89A03A2CC54 Q30412608-A9FF1B04-E3FB-4010-9DD6-E8FE9C0F1220 Q30416558-9E3EC1A4-C13D-419A-B64A-E6D81431DA3C Q30417367-0B8DACCB-2216-4B83-A262-5669B9AD1445 Q30417903-38ADA9D7-5893-4A84-A1E6-EB9308704D37 Q30422990-AA85A2B2-7424-486C-B8A5-4B83F9645DDF Q30427316-B1B7F418-A006-4427-8F71-DC0699FDFC5B Q30429420-50EB07EA-B209-4360-A817-8A3F3AB9CEF5 Q31074202-57307148-0023-411B-89B4-2990AC39F448 Q33300810-82E75BDE-DC42-4995-B9E5-C2C809A5096D Q33335357-DEA53658-84F4-475D-96A4-B53886C47698 Q33396570-209012AB-E5A9-43A2-8B85-32E7A0B624E6 Q33603268-2BB72382-AE47-4585-9740-B06FF89D45D5 Q33712836-954C8DA7-DDD4-42FB-A36E-3158F2946B1D Q33767332-9DD9BDC5-6AE3-4E17-A615-3C092AD54D43 Q34898648-6BDAD9AB-A15F-4A2D-BBC4-EBE512F91776 Q35043796-E75C5D76-E86B-470D-88AF-5E8AEA7F033D Q35175219-8D24280D-67A1-49A0-A9E6-360BBA39DAB6 Q35381351-A505340C-3B69-4C64-B18F-1696D5249319 Q35621624-F5348B8F-A07B-4FF3-9665-6FA6D23699B1 Q35679069-C89266D5-B9D1-4810-B8D6-A9ED817E96C0 Q35777041-578B1121-428C-404F-8349-9C881EE3C55F Q35903294-77D88BE5-1CF3-42A2-8640-2D9F7A857BF7 Q35953146-D64E7629-6D5A-41A0-906F-A3FBE9A24344 Q35988464-B8CE1C75-5591-4814-B532-324697F62B63 Q36285918-42FF83BF-D592-419D-BBC5-9A0BF278916B Q36291684-8BFEB192-867F-4EA6-9727-5D665D20CC92 Q36829805-B3255BA2-E8EF-49E2-BAF6-04D85CFB2D00 Q36923553-9872258C-7717-490B-9AEE-E7EFC7BB7ADC Q36950174-A26C8623-644A-4F06-BDD6-C0F1B90B521E Q37043623-D1439C9C-6B8E-49DE-AE45-2B26C7A85893 Q37092215-3429810C-446C-44CA-8650-144B21A46858 Q37143257-D4F551B4-1EF1-4927-A875-D2138200606D Q37221422-B553597C-64C5-41C3-83E4-8324C6F8024F Q37409181-E54B0B15-0709-439B-8A81-76381A842F80 Q37776088-052A0061-5DDD-4195-A30E-8D4E9724F676

P2860

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

http://www.wikidata.org/entity/Q34488620

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@ast

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@en

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@nl

type

label

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@ast

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@en

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@nl

prefLabel

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@ast

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@en

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@nl

P1433

Q34488620-4166794B-2E63-4F5C-AEDB-79035FF2E1D3

P1476

Q34488620-185D14A6-C334-43E4-BC1A-BD6A1F20AAC6

P2093

Q34488620-28DFAA66-3170-4FB5-8132-AFDAD8F8DB30

Q34488620-2A0964AE-378B-4534-8A38-22BBAE832E11

Q34488620-3D5B8277-9E42-43C1-98F6-99DCDD410A75

Q34488620-5830B21A-77BD-4425-A594-B20568E13354

Q34488620-58CB5442-119F-4E4D-8F5F-275EB11A4D24

Q34488620-6517C954-8D36-45BD-9D85-9C1D125BCBA8

Q34488620-68444782-7B96-40DF-9EB2-8F4629D3696D

Q34488620-BFE1E747-C606-41FF-87EF-B614A5D4EBFF

Q34488620-C5AF6A77-98D8-4B4D-8D2D-EC90CC8D5C10

Q34488620-C90F8884-ABCF-4E34-A8B6-A4ADCFEA8706

P304

Q34488620-ABFFD22C-EA68-45F3-BC54-A9612A245F15

P31

Q34488620-2360CCA6-A61B-4735-B9AD-147A48EC460B

P356

Q34488620-294375A3-851D-46BB-9C3D-13C289D7E0A5

P407

Q34488620-D3EFB303-0B5E-4258-9B68-E45898BB5A52

P433

Q34488620-721020D0-0E40-4406-AEE1-6C761C0EDE20

P478

Q34488620-3DB37FF2-F145-4C1B-B947-768EBA3AA416

P50

Q34488620-BD05EAD0-68DF-4170-97BB-5E5A590434CE

Q34488620-E776C1C6-D37E-4D3E-839B-C0E734BEEF84

P577

Q34488620-BED8BE2D-7202-47C3-878C-D9A8E16A7FDC

P5875

Q34488620-48EF0C66-91D0-4995-BDB1-71CC59DE711A

P698

Q34488620-48A75675-798B-40D0-8670-5164BC68C023

P921

Q34488620-1D93640B-B4AD-4D83-84FB-5C3A2E8099F4

P356

CLINCHEM.2005.059139

P1433

Clinical Chemistry

P1476

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.

@en

P2093

Gilbert M Eisner

http://www.w3.org/2001/XMLSchema#string

Hironobu Sanada

http://www.w3.org/2001/XMLSchema#string

John C Pezzullo

http://www.w3.org/2001/XMLSchema#string

Junichi Yatabe

http://www.w3.org/2001/XMLSchema#string

Midori Sasaki

http://www.w3.org/2001/XMLSchema#string

Pedro A Jose

http://www.w3.org/2001/XMLSchema#string

Robin A Felder

http://www.w3.org/2001/XMLSchema#string

Sanae Midorikawa

http://www.w3.org/2001/XMLSchema#string

Scott M Williams

http://www.w3.org/2001/XMLSchema#string

Shigeatsu Hashimoto

http://www.w3.org/2001/XMLSchema#string

P304

352-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2005.059139

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Marylyn D. Ritchie

P577

2006-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7333274

http://www.w3.org/2001/XMLSchema#string

P698

16439609

http://www.w3.org/2001/XMLSchema#string

P921

single-nucleotide polymorphism